1 ML pegloticase 8 MG/ML Injection [Krystexxa]
RxNorm concept 1011657, branded drug (sbd). Prescribable name: Krystexxa 8 MG in 1 ML Injection.
- RxCUI
- 1011657
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1011657 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Krystexxa (as uricase protein) 8 MG per 1 ML Injection; Krystexxa 8 MG per 1 ML Injection
Related concepts
- pegloticase 8 MG/ML (SCDC, consists of)
- pegloticase 8 MG/ML [Krystexxa] (SBDC, consists of)
- Injection (DF, has dose form)
- Krystexxa (BN, has ingredient)
- 1 ML pegloticase 8 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1011657 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1011657 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1011657. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.